By Shawn M. Carter
Pancreatic islet transplantation may reduce transplant failure risk and boost long-term survival vs. insulin alone in kidney transplant recipients with type 1 diabetes, new data show.
“Although islet transplantation has previously been shown to improve glycemic control compared with conventional insulin therapy, little was known about its long-term impact until now,” lead researcher Mehdi Maanaoui, MD, a nephrologist at the Centre Hospitalier Régional Universitaire de Lille, in France, said in a press release. Read more in Healio.